News
Headache on the Hill 2024 & the Inaugural Year for AHS Advocacy Scholars
AHS recognizes that to fulfill its core goal of improving the lives of people impacted by migraine and other headache disorders, healthcare advocacy is essential.
Mentorship Opportunity: 2024 Headache® Assistant Editor Program
Adult neurology residents, pediatric neurology residents, postdoctoral researchers, and headache medicine fellows are eligible to apply for a 2-year term, beginning July 1, 2024 and ending June 30, 2026.
New AHS Leadership Development Opportunities Available Fall 2023
This fall, the American Headache Society is proud to offer two programs dedicated to developing leaders within the Society and field of Headache Medicine. These professional development programs were designed to support AHS members at different stages in their careers.
Input Requested
The American Headache Society (AHS) and National Institute of Neurological Disorders and Stroke (NINDS) request your input during the Headache Research Priorities Public Comment Period.
Statement in Observance of Hispanic Heritage Month
As an American citizen growing up outside of the United States (mainland), I do not recall celebrating Hispanic Heritage month with particular fervor.
Advocating for Patients with Migraine: Q&A
Amaal Starling, MD, FAHS, discusses how doctors also function as migraine warriors
Advocacy in Action: AHS Proposes Changes to Coverage for Home-use Oxygen for Cluster Headache Attacks
Home-use oxygen for the treatment of cluster headache has not been a coverable benefit for Medicare and Medicaid beneficiaries. This is despite the therapy being a proven safe and effective way to abort a cluster headache attack.
Advocacy in Action: Investing in Graduate Medical Education
American Headache Society (AHS) joined with 85 other medical associations and specialty societies in praise of a renewed Congressional pledge to support physician training.
Advocacy in Action: AHS Urges CMS to Rescind Most Favored Nation (MFN) Model
On January 26th, AHS president, Peter Goadsby, MD, PhD, FAHS sent a letter to Centers for Medicare & Medicaid Services (CMS) urging an immediate stop to the implementation of the recently finalized “Most Favored Nation” (MFN) Model.
Our Joint Statement on Oxygen Therapy for Cluster Headache
We advocate for the Centers for Medicare & Medicaid Services to cover home use oxygen therapy for the acute treatment of cluster headache attacks
AHS & AMF Commitment on the Impact of Recent National Events, Racism, and Healthcare Disparities
Racism is a public health issue and as a scientific healthcare organization and patient advocacy organization we recognize the need for us to take an active role.
How Headache Evaluates Manuscript Submissions
Interested in submitting a manuscript to Headache? Find out exactly what the editors are looking for here.
Resident Education Program: Q&A with Matthew Robbins, MD, FAHS
Matthew Robbins, MD, FAHS, AHS Board Member and Chair of the Resident Education Program, is an Associate Professor of Neurology at the Albert Einstein College of Medicine and Neurologist at the Montefiore Headache Center in New York.
Clinical Studies Show Impact of Migraine Across Various Stages of Women’s Lives
Clinical Studies at American Headache Society 60th Annual Scientific Meeting Show Impact of Migraine Across Various Stages of Women’s Lives